215 related articles for article (PubMed ID: 36114601)
1. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real-world clinical practice.
Song H; Hu Z; Zhang S; Yang L; Liu Y; Wang T
Dermatol Ther; 2022 Nov; 35(11):e15821. PubMed ID: 36114601
[TBL] [Abstract][Full Text] [Related]
2. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P; Klahan SO
Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
[TBL] [Abstract][Full Text] [Related]
3. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet-rich plasma for stable nonsegmental vitiligo.
Fawzy M; Al-Mokadem S; Alshereef M; Elkholy B
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12929. PubMed ID: 37984828
[TBL] [Abstract][Full Text] [Related]
4. Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial.
Thind A; Vinay K; Mehta H; Bishnoi A; Kumaran MS; Parsad D
Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12960. PubMed ID: 38480997
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo.
Neinaa YME; Lotfy SS; Ghaly NR; Doghaim NN
Dermatol Ther; 2021 Mar; 34(2):e14813. PubMed ID: 33497514
[TBL] [Abstract][Full Text] [Related]
6. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on the use of fractional CO
Bakr RM; Abdel-Gaber RM; Tawfik YM
Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
[TBL] [Abstract][Full Text] [Related]
8. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
Majid I
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
[TBL] [Abstract][Full Text] [Related]
9. Topical Band-pass Filter Cream (TBFC)-assisted home-based NB-UVB: A must-know Alternative to artificial phototherapy.
Sonthalia S
J Cosmet Dermatol; 2021 Jul; 20(7):2141-2147. PubMed ID: 33977652
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
Shin J; Lee JS; Hann SK; Oh SH
Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
[TBL] [Abstract][Full Text] [Related]
11. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
Fai D; Cassano N; Vena GA
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
[TBL] [Abstract][Full Text] [Related]
12. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
13. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
[TBL] [Abstract][Full Text] [Related]
14. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
15. Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative study.
Kanokrungsee S; Khunkhet S; Rojhirunsakool S; Thadvibun K; Sahaspot T
Dermatol Ther; 2022 Jan; 35(1):e15198. PubMed ID: 34750933
[TBL] [Abstract][Full Text] [Related]
16. Vitiligo, NB-UVB and tacrolimus: our experience in Naples.
Baldo A; Lodi G; Di Caterino P; Monfrecola G
G Ital Dermatol Venereol; 2014 Feb; 149(1):123-30. PubMed ID: 24566573
[TBL] [Abstract][Full Text] [Related]
17. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
[No Abstract] [Full Text] [Related]
19. A comparative interventional study of narrowband ultraviolet B alone and narrowband ultraviolet B in combination with microneedling in patients with stable vitiligo.
Kaur A; Barman KD; Sahoo B; Choudhary P
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):357-363. PubMed ID: 36419200
[TBL] [Abstract][Full Text] [Related]
20. UVB phototherapy in the treatment of vitiligo: State of the art and clinical perspectives.
Bouceiro Mendes R; Alpalhão M; Filipe P
Photodermatol Photoimmunol Photomed; 2022 May; 38(3):215-223. PubMed ID: 34626483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]